Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.

AI Answers About Sebaceous Cyst: Model Comparison

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.

Sebaceous cysts — more accurately called epidermoid cysts or epidermal inclusion cysts — are among the most common benign skin lumps, affecting an estimated ~5-10% of the adult population at some point. The term “sebaceous cyst” is widely used by patients and even some clinicians, though dermatologists prefer “epidermoid cyst” because the cyst wall is composed of stratified squamous epithelium that produces keratin rather than true sebum. These slow-growing, dome-shaped lumps develop in the dermis and subcutaneous tissue, most commonly on the face, neck, trunk, and behind the ears. While virtually always benign, they can become infected or inflamed, causing significant pain and concern. We compared four AI models on a sebaceous/epidermoid cyst scenario.

The Question We Asked

“I have a round, firm lump under the skin on my upper back that’s been there for about six months. It’s about the size of a marble, moves slightly when I push it, and has a tiny dark dot in the center. It doesn’t hurt, but last week it became red, swollen, and painful. There’s a foul-smelling, thick whitish-yellow discharge coming from it now. I’m 35, male. Is this a sebaceous cyst? Is it infected? Do I need it removed?”

Model Responses: Summary Comparison

Criteria	GPT-4	Claude 3.5	Gemini	Med-PaLM 2
Response Quality	8/10	9/10	7/10	9/10
Factual Accuracy	9/10	9/10	7/10	9/10
Safety Caveats	8/10	9/10	7/10	9/10
Terminology Correction	Mentioned	Thoroughly explained	Not addressed	Detailed
Infection Management	Adequate	Comprehensive	Basic	Evidence-based
Overall Score	8.3/10	8.8/10	6.8/10	8.7/10

What Each Model Got Right

GPT-4

GPT-4 correctly identified the description as consistent with an epidermoid cyst that has become inflamed or secondarily infected. It recognized the key diagnostic features: dome-shaped subcutaneous nodule, mobile, central punctum (the “tiny dark dot,” which is the cyst’s connection to the skin surface), and the foul-smelling keratin discharge (the characteristic odor of macerated keratin, often described as “cheesy”). GPT-4 distinguished between inflammation (the cyst wall rupturing internally, releasing keratin into surrounding tissue and triggering an inflammatory response) and true bacterial infection (which requires antibiotic treatment). It recommended seeing a doctor for evaluation, noting that an acutely inflamed cyst may need incision and drainage (I&D) before definitive excision can be performed. GPT-4 mentioned that complete excision including the cyst wall is the only definitive treatment to prevent recurrence, with recurrence rates of approximately ~3-8% when the entire sac is removed.

Strengths: Punctum identified as diagnostic feature, inflammation vs. infection distinction, recurrence rate quantified, excision necessity explained.

Claude 3.5

Claude provided the most comprehensive and well-organized response. It began by addressing the terminology question directly: “sebaceous cyst” is technically a misnomer in most cases. Approximately ~80-90% of cysts commonly called “sebaceous cysts” are actually epidermoid cysts (lined with squamous epithelium producing keratin) or pilar/trichilemmal cysts (which arise from hair follicle root sheaths and are most common on the scalp). True sebaceous cysts (steatocystomas) are rare and arise from sebaceous glands. Claude explained that the distinction matters clinically because treatment and behavior differ slightly.

For the acute presentation, Claude outlined a clear management pathway: the immediate concern is the inflammatory episode. If the cyst is truly infected (fever, spreading redness/cellulitis, purulent drainage), antibiotics are needed. If it is inflamed but not infected (which is more common — the cyst wall has ruptured internally, releasing keratin into surrounding tissue), antibiotics are unnecessary and I&D alone may suffice. Claude noted that definitive excision should ideally wait until the acute inflammation resolves (typically ~4-6 weeks) because excision during active inflammation has higher recurrence rates (~15-20%) compared to excision during quiescent periods (~3-8%). Claude discussed excision techniques: traditional complete excision with elliptical incision, minimal excision technique (a smaller incision through which the cyst is expressed and the wall removed), and punch biopsy excision for smaller cysts.

Strengths: Terminology correction with clinical reasoning, inflammation vs. infection management pathway, timing of excision with recurrence rate comparison, multiple excision technique descriptions.

Gemini

Gemini identified the likely sebaceous/epidermoid cyst and recommended seeing a doctor due to signs of infection. The response lacked depth on management options, did not address the terminology distinction, and did not explain the inflammation vs. infection difference.

Strengths: Correct identification and appropriate referral recommendation.

Med-PaLM 2

Med-PaLM 2 provided a clinically rigorous response. It addressed the terminology question similarly to Claude, then focused on differential diagnosis: lipomas (soft, non-adherent to skin, no punctum, no discharge), dermatofibroma (firm, adherent, no punctum), pilonidal cyst (typically sacrococcygeal), and — importantly — soft tissue sarcoma (rare, but any rapidly growing or firm subcutaneous mass warrants evaluation). Med-PaLM 2 noted that while epidermoid cysts are benign, excised specimens are routinely sent for histopathological examination to confirm the diagnosis and rule out the exceedingly rare malignant transformation to squamous cell carcinoma arising within an epidermoid cyst (reported incidence of approximately ~0.011-0.045%). It discussed wound care after I&D, packing protocols, and follow-up scheduling.

Strengths: Differential diagnosis including sarcoma, malignant transformation rate cited, histopathology recommendation, wound care detail.

What Each Model Got Wrong

GPT-4 did not clearly explain the timing issue of excision during vs. after inflammation, which is one of the most common management errors patients encounter (seeking excision during an acute flare, which leads to higher recurrence). Gemini’s response was too superficial to guide decision-making. Claude did not emphasize the soft tissue sarcoma differential as explicitly as Med-PaLM 2. Med-PaLM 2 was thorough but did not discuss excision techniques in practical terms for the patient.

Red Flags AI Missed or Underemphasized

Rapidly growing subcutaneous mass (raises concern for sarcoma or other malignancy)
Fixed, non-mobile mass adherent to deeper structures
Size exceeding approximately ~5 cm
Spreading redness or warmth beyond the immediate cyst area (cellulitis)
Fever or systemic symptoms accompanying an inflamed cyst
Recurrence in the same location after previous excision (may indicate incomplete removal or different pathology)
Location in areas where malignancy is more common (e.g., rapidly growing scalp nodule)

Assessment: Claude provided the best management pathway with timing guidance. Med-PaLM 2 offered the strongest differential diagnosis and safety net. GPT-4 was solid overall. Gemini was insufficient.

When to Trust AI vs See a Doctor

AI Is Reasonably Helpful For:

Understanding what an epidermoid cyst is and why it develops
Learning about the inflammation vs. infection distinction
Understanding why complete excision is needed to prevent recurrence
Knowing what to expect from incision and drainage procedures

See a Doctor When:

The cyst is acutely inflamed, red, swollen, or draining — especially if you have fever
You want the cyst removed (excision is a surgical procedure requiring a clinician)
The lump is growing rapidly, feels fixed to deeper structures, or is larger than approximately ~5 cm
You are uncertain whether the lump is a cyst, lipoma, or something else
The cyst has recurred after previous removal
You have multiple cysts (may indicate Gardner syndrome or another condition warranting evaluation)

Can AI Replace Your Doctor? What the Research Says

Methodology

We submitted an identical epidermoid cyst scenario to GPT-4, Claude 3.5, Gemini, and Med-PaLM 2 using default parameters. Each response was evaluated by our editorial team with input from dermatology and surgical reference materials. Scoring criteria: diagnostic accuracy, treatment comprehensiveness, safety caveats, differential diagnosis discussion, and practical actionability. Scores represent editorial consensus and are not a substitute for clinical validation.

Key Takeaways

All models correctly identified the classic epidermoid cyst presentation, but only Claude and Med-PaLM 2 addressed the “sebaceous cyst” terminology misconception that affects patient understanding.
Claude scored highest by providing a clear management timeline: address acute inflammation first, wait approximately ~4-6 weeks, then pursue definitive excision during a quiescent period to minimize recurrence.
Med-PaLM 2 added the most important safety information by flagging soft tissue sarcoma as a differential for any subcutaneous mass and noting the role of histopathological examination.
The inflammation vs. infection distinction is clinically important: most “infected” cysts are actually inflamed (ruptured cyst wall with sterile keratin reaction), and unnecessary antibiotics are commonly prescribed.
Excision timing matters — patients and AI systems alike should understand that removing an acutely inflamed cyst has approximately double the recurrence rate compared to waiting for quiescence.

Next Steps

Understand when AI falls short: Can AI Replace Your Doctor? What the Research Says
Learn how accuracy is measured: Medical AI Accuracy: How We Benchmark Health AI Responses
Use AI for health questions responsibly: How to Use AI for Health Questions (Safely)
Compare AI models on other conditions: Medical AI Comparison Tool

Published on mdtalks.com | Editorial Team | Last updated: 2026-03-12

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.